Alderley Analytical
Bioanalytical CRO running GLP/GCP-compliant assays for pharma, biotech and CRO clients developing new drugs
Highlights
- New on EvolcAdded 2026-10-30
About Alderley Analytical
Alderley Analytical is a bioanalytical contract research organisation (CRO) that develops, validates and runs bioanalysis assays for drug development. Its work covers mass spectrometry with UHPLC, ligand binding assays such as EIA, ELISA and ECLIA, and a Thermo Fisher WATSON LIMS.
Clients are typically pharmaceutical, biotech and other CROs, and the services span discovery, pre-clinical and clinical stages for small molecules, peptides, oligonucleotides, biomarkers and large molecules. The laboratory is GLP and GCP accredited and validates bioanalytical methods to current regulatory guidelines.
Founded in 2013, the company is based in Tytherington, Macclesfield, Cheshire, UK. It was acquired by Synexa Life Sciences in 2024 and now operates as part of that group. Hiring is for bioanalytical scientists with GLP and GCP experience, project leaders and quality assurance auditors.
Product: Contract bioanalysis services (method development, validation and sample analysis) for drug development, using LC-MS/MS and ligand binding assays.
Jobs at Alderley Analytical
Leadership
- Sally Hannam · CSO / FounderSource: company website
- Paul Holme · CEO / FounderSource: company website
- Claire Wildgoose · COO / FounderSource: company website
More biotech & pharma companies
Alimera Sciences
Develops and commercialises ophthalmic medicines for patients with chronic retinal diseasesNew on EvolcAlldna
Microbiome research and data insights for laboratories and research institutions worldwideYoung companyNew on EvolcAllergy Therapeutics (UK)
Develops and manufactures allergy immunotherapy treatments and diagnostics for patients and healthcare professionalsNew on EvolcAlturix
Develops and supplies prescription medicines and a bedwetting support app for the NHS and international healthcare marketsNew on EvolcAmaxa
Pharmaceutical company supplying prescription and OTC medicines to specialist markets across Europe, Central Asia and the Middle EastNew on EvolcAmgen
Biotechnology company developing and manufacturing biologic medicines for serious illnesses, with UK sites in Cambridge and UxbridgeNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- BambooHR
- CookieYes
- Google Tag Manager
- Google reCAPTCHA
- Hotjar
- LiteSpeed
- WordPress
- jQuery